Biosimilar Sciences PR LLC is pleased to announce its strategic partnership with Ocyonbio, engaging their state-of-the-art CDMO (Contract Development and Manufacturing Organization) services to advance the commercialization of its biosimilar molecule across the North American territory, including the United States, Canada, and Mexico. This collaboration marks a significant milestone, as the biosimilar molecule — licensed […]
